CP-675,206 monoclonal antibody

CP-675,206 · AstraZeneca

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CP-675,206 monoclonal antibody, covering 2012-06-06 to 2012-06-06. Get the full timeline:

Most recent: Clinical Trial Update: Study to Compare Two Formulations of CP-675,206 Monoclonal Antibody [Phase 1]